On Tuesday,
Canbud Distribution Corp. (CSE: CBDX, Forum) stated that its leadership team had signed a Letter of Intent with Hempsana Inc. to develop and manufacture CBD products for distribution to the medical-patient channel.
Canbud CFO Raj Ravindran commented that the partnership with Hempsana is further evidence of the Company’s aggressive approach to create accretive revenue streams.
“This partnership will expand to create more partnerships with global CBD brands to serve the Canadian market as well as other international jurisdictions.”
For more details on this story, click
here.
The science and technology health and wellness Company made news recently as it works to advance the development of a decentralized based consumer
feedback and chain of custody platform for its psychedelics/functional mushrooms, CBD and plant-based product offerings -
CanbudProve.
FULL DISCLOSURE: Canbud Distribution Corp. is a client of Stockhouse Publishing.